CREATE (Center for Research, Education and Training Enhancement)

CREATE(研究、教育和培训增强中心)

基本信息

项目摘要

 DESCRIPTION (provided by applicant): This project brings together a long-standing need for Minority Serving Institutions to better fulfill their leading role in creating a strong and inclusie biomedical workforce. Florida A&M University currently trains Master's degrees in Molecular Cellular Biology, and Community Psychology as well as Doctorate degrees in Pharmacology, Public Health, Pharmacoepidemiology / Health Outcomes, Environmental Toxicology, Biomedical Engineering and Drug Delivery. Despite ranking among the top producers of black doctoral degree recipients in life sciences, our success in the contribution of independent investigators from biomedical and educationally underserved populations has been low. Increasing the quality of research education and the development of trainees in our research community is a top priority of the PI and our institution. This application maps our path forward to meet this challenge (in this application, "biomedical" refers to biological, behavioral, social, clinical, and environmental health sciences). We have identified a clear need for a new and innovative Center for Research Education and Training Excellence (CREATE) at Florida A&M University, and are seeking funding to establish this important resource. CREATE will serve intramural and extramural students and faculty who face potential barriers in their research careers, specifically addressing gaps in their self-preparedness and providing strategic lines of environmental support to foster a more productive research career among CREATE participants.
 描述(由申请人提供):该项目汇集了少数族裔服务机构的长期需求,以更好地发挥其在创建强大和包容的生物医学劳动力方面的主导作用,佛罗里达农工大学目前培养分子细胞生物学和社区心理学硕士学位。以及药理学、公共卫生、药物流行病学/健康结果、环境毒理学、生物医学工程和药物输送方面的博士学位,尽管位居顶级黑人生产者之列。对于生命科学领域的博士学位获得者来说,我们在生物医学和教育服务不足人群中的独立研究人员的贡献方面的成功率很低,提高研究教育的质量和研究界受训人员的发展是 PI 和我们机构的首要任务。该应用程序描绘了我们应对这一挑战的前进道路(在该应用程序中,“生物医学”指的是生物、行为、社会、。 我们已经明确需要佛罗里达农工大学建立一个新的创新研究教育和培训卓越中心 (CREATE),并正在寻求资金来建立这一重要资源。在研究生涯中面临潜在障碍的学生和教师,特别是解决他们自我准备方面的差距,并提供战略性的环境支持,以促进 CREATE 参与者更富有成效的研究生涯。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Seth Y Ablordeppey其他文献

Seth Y Ablordeppey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Seth Y Ablordeppey', 18)}}的其他基金

Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
  • 批准号:
    10412227
  • 财政年份:
    2022
  • 资助金额:
    $ 30.4万
  • 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
  • 批准号:
    10610473
  • 财政年份:
    2022
  • 资助金额:
    $ 30.4万
  • 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
  • 批准号:
    10799162
  • 财政年份:
    2022
  • 资助金额:
    $ 30.4万
  • 项目类别:
A New Approach for the Development of Novel Antipsychotic Drugs
开发新型抗精神病药物的新方法
  • 批准号:
    9208785
  • 财政年份:
    2016
  • 资助金额:
    $ 30.4万
  • 项目类别:
A New Approach for the Development of Novel Antipsychotic Drugs
开发新型抗精神病药物的新方法
  • 批准号:
    8999079
  • 财政年份:
    2016
  • 资助金额:
    $ 30.4万
  • 项目类别:
CREATE (Center for Research, Education and Training Enhancement)
CREATE(研究、教育和培训增强中心)
  • 批准号:
    9754165
  • 财政年份:
    2015
  • 资助金额:
    $ 30.4万
  • 项目类别:
CREATE (Center for Research, Education and Training Enhancement)
CREATE(研究、教育和培训增强中心)
  • 批准号:
    9536106
  • 财政年份:
    2015
  • 资助金额:
    $ 30.4万
  • 项目类别:
Development of Novel Agents for CNS-related Diseases
中枢神经系统相关疾病新药的开发
  • 批准号:
    8289462
  • 财政年份:
    2009
  • 资助金额:
    $ 30.4万
  • 项目类别:
Development of Novel Agents for CNS-related Diseases
中枢神经系统相关疾病新药的开发
  • 批准号:
    7910593
  • 财政年份:
    2009
  • 资助金额:
    $ 30.4万
  • 项目类别:
Development of Novel Agents for CNS-related Diseases
中枢神经系统相关疾病新药的开发
  • 批准号:
    7712516
  • 财政年份:
    2009
  • 资助金额:
    $ 30.4万
  • 项目类别:

相似海外基金

Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
  • 批准号:
    10797938
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
Simulating Ancestrally Unbiased Tumor Evolution To Interrogate Drug Resistance
模拟祖先无偏见的肿瘤进化来询问耐药性
  • 批准号:
    10687776
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
种族和民族对接受 CDK4/6 抑制剂治疗的激素受体阳性乳腺癌患者预后的影响
  • 批准号:
    10762267
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
Genetic and neuroanatomical basis of neuropsychiatric symptoms in Alzheimer's disease in populations of diverse ancestry
不同血统人群中阿尔茨海默病神经精神症状的遗传和神经解剖学基础
  • 批准号:
    10567606
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans about the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars
赤裸裸的真相:通过纠正针对非裔美国人的关于 FDA 提议禁止薄荷卷烟和调味雪茄的虚假信息来追求健康公平
  • 批准号:
    10740281
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了